Sepsis Diagnostic Market Intelligence Report - Global Forecast to 2027

Sepsis Diagnostic Market Intelligence Report - Global Forecast to 2027

The Global Sepsis Diagnostic Market is projected to reach USD 812.92 million by 2027 from USD 462.38 million in 2021, at a CAGR 9.86% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Sepsis Diagnostic Market size was estimated at USD 197.15 million in 2021 and expected to reach USD 215.04 million in 2022, at a CAGR 9.66% to reach USD 342.84 million by 2027.
• The Asia-Pacific Sepsis Diagnostic Market size was estimated at USD 102.65 million in 2021 and expected to reach USD 113.91 million in 2022, at a CAGR 10.28% to reach USD 184.65 million by 2027.
• The Europe, Middle East & Africa Sepsis Diagnostic Market size was estimated at USD 162.57 million in 2021 and expected to reach USD 178.18 million in 2022, at a CAGR 9.83% to reach USD 285.42 million by 2027.

Market Segmentation & Coverage:

The report on sepsis diagnostic identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the sepsis diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:

Testing Type:

• Laboratory Testing
• PoC Testing

Technology:

• Flow Cytometry
• Immunoassays
• Microbiology
• Molecular Diagnostics

Product:

• Assay Kits and Reagents
• Blood Culture Media
• Instruments
• Software

Method:

• Automated Diagnostics
• Conventional Diagnostics

Pathogen:

• Bacterial Sepsis
  • Gram-Negative Bacteria
  • Gram-Positive Bacteria
• Fungal Sepsis

End-user:

• Hospitals
• Pathology & Reference Laboratories
• Research Laboratories & Academic Institutes

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Florida
    • Illinois
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbott Laboratories
• Alifax S.r.l.
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• bioMérieux SA
• Boditech Med Inc.
• Bruker Corporation
• Cerner Corporation
• CytoSorbents Corporation
• EKF Diagnostics
• Epic Systems Corporation
• F. Hoffmann-La Roche AG
• GenMark Diagnostics
• Immunexpress Inc.
• Koninklijke Philips N.V.
• Luminex Corporation
• McKesson Corporation
• Response Biomedical Corporation
• Seegene Inc.
• Thermo Fisher Scientific, Inc.
• Wolters Kluwer N.V.